E Fund Management Co., Ltd. Eq Rx, Inc. Transaction History

E Fund Management Co., Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.66 - $2.31 $10,755 - $14,966	-6,479 Reduced 19.44%	26,843 $60,000
Q2 2023 Aug 11, 2023	SELL	$1.61 - $1.96 $47,105 - $57,345	-29,258 Reduced 46.75%	33,322 $62,000
Q1 2023 May 11, 2023	SELL	$1.8 - $2.83 $3,321 - $5,221	-1,845 Reduced 2.86%	62,580 $121,000
Q4 2022 Feb 14, 2023	BUY	$2.05 - $5.5 $49,603 - $133,083	24,197 Added 60.15%	64,425 $158,000
Q3 2022 Nov 14, 2022	BUY	$0.94 - $5.99 $17,251 - $109,934	18,353 Added 83.9%	40,228 $199,000
Q2 2022 Aug 15, 2022	BUY	$3.2 - $5.69 $70,000 - $124,468	21,875 New	21,875 $103,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.